# One Week Versus Three Week in Adjuvant Radiotherapy in Breast Cancer

> **NCT03788213** · NA · RECRUITING · sponsor: **Tata Medical Center** · enrollment: 2100 (estimated)

## Conditions studied

- Breast Cancer Female

## Interventions

- **RADIATION:** 3 week RT
- **RADIATION:** 1 week RT

## Key facts

- **NCT ID:** NCT03788213
- **Lead sponsor:** Tata Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2019-03-26
- **Primary completion:** 2029-03-26
- **Final completion:** 2029-03-26
- **Target enrollment:** 2100 (ESTIMATED)
- **Last updated:** 2024-10-23

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03788213

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03788213, "One Week Versus Three Week in Adjuvant Radiotherapy in Breast Cancer". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03788213. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*